Hi, my name is Andy Kent. I am an autistic, high-functioning individual who has faced numerous challenges and setbacks throughout my life. Although I no longer work, I previously held the position of an executive trainer chef, specializing in troubleshooting any kitchen within the Midlands and North UK. My career allowed me to work for […]
The post “On The Brink of Suicide: Health and Safety Issues in Private Prescription Cannabis Healthcare” appeared first on I Am Billy.
At Curaleaf Clinic (formally Sapphire Clinics), we see patients with a range of conditions –
Sales of legal cannabis in the USA are projected to reach $33 billion in 2024,
Ecstasy pills with higher than average levels of MDMA are currently being sold in the
Introduction Prescription cannabis patients often face subpar care while trying to navigate their new medicine. From doctors informing them that “product is out of stock” to pharmacists questioning, “What’s a COA?” (Certificate of Analysis), patients are left disheartened and frustrated. This blog explores the challenges faced by these patients and emphasizes the need for better […]
The post Navigating Prescription Cannabis appeared first on I Am Billy.
In this article, we explore the stigma associated with cannabis, the challenges faced by ethnic communities in the UK, and offer guidance for those seeking medical cannabis treatment.
The post Ethnic Diversity in Cannabis: Navigating Stigma and Health Challenges first appeared on PatientsCann UK.
A groundbreaking study by researchers at the Comprehensive Center for Pain & Addiction has highlighted the potential of cannabis terpenes to provide relief from chemotherapy-induced neuropathic pain. This study, published in the journal PAIN, suggests that terpenes from Cannabis sativa may be as effective as morphine in managing chronic pain, offering a promising alternative with […]
The post Cannabis Terpenes as Effective as Morphine for Pain Relief with Fewer Side Effects appeared first on I Am Billy.
Introduction A recent study has uncovered intriguing findings about the use of medical marijuana in treating depression and anxiety. The research, which included individuals diagnosed with clinical depression, revealed that those using medicinal cannabis reported lower depression scores compared to non-users. This blog delves into the study’s findings and discusses the implications for the treatment […]
The post Baltimore researchers find cannabis could be effective treatment Anxiety and Depressive Symtoms appeared first on I Am Billy.
Life Before Medicinal Cannabis My name is Antonín, and I am 41 years old. After an accident at work, I have been on a disability pension for the past ten years. For the last 17 years, I have lived in Scotland. My mother and father, along with my sister and brother and their families, reside […]
The post My Journey: From Disability to Wellness with Medicinal Cannabis appeared first on I Am Billy.
Medical cannabis cultivator Glass Pharms has officially delivered its first crop to the first UK-based
Introduction: A Landmark Achievement for Patient Care After six long years, UK patients can finally rejoice. Releaf has announced a significant breakthrough that promises to end the persistent supply issues that have plagued the therapeutic market. This development marks a new era in patient care, ensuring a reliable supply of essential medications. Ensuring Security of […]
The post UK Patients Have Been Waiting 6 Entire Years for This to Happen!! appeared first on I Am Billy.
Prescription Cannabis Prescription cannabis has been gaining traction globally, and the UK is no exception. With a growing awareness of its therapeutic benefits, more patients are turning to cannabis-based medicines. However, the burgeoning variety of cannabis products raises significant questions about the quality and consistency of the supply. Medications In the UK, the number of […]
The post A Green Flood ? 474 Prescription Cannabis Products in the UK Market appeared first on I Am Billy.
In 1980, 44 years ago, I experienced a herniated disc at L4/5 while working as a professional driver. It was my mistake due to inattentiveness and extremely heavy lifting during the loading of gear parts. Since then, I have repeatedly suffered from the same symptoms, which have worsened over the years, especially in the cold […]
The post My Journey Through Chronic Pain: A Personal Battle with Herniated Discs, Arthritis, and Lyme Disease appeared first on I Am Billy.
Life as a Heavy Equipment Operator I work as a heavy equipment operator, handling bulldozers, agricultural tractors, and excavators. My days are filled with the roar of machinery and the satisfaction of shaping the land. At home, I share my life with my girlfriend of 15 years and our 13-year-old dog, who provide me with […]
The post From Garden to Career: How Growing My Own Medicine Led to Professional Success appeared first on I Am Billy.
Top chemists at the University of Sussex are developing new ways of administering cannabis-based medicines
A new UK task force, headed up by leading figures in medicine and life sciences,
In the realm of consumer safety, minimum standards form a critical safety net that allows
Introduction Thanks to the bravery of young Billy Caldwell on November 1st, 2018, the United Kingdom took a significant step in healthcare by legalising the prescription of cannabis-based medications by Specialist Clinicians registered with the General Medical Council (GMC). This decision was intended to provide patients suffering from various conditions with access to a new […]
The post The Legalisation of Prescription Cannabis in the UK: Progress and Challenges appeared first on I Am Billy.
Introduction The use of cannabis for medicinal purposes has gained significant traction over recent years. Advocates argue its potential benefits for various conditions, particularly for children suffering from severe epilepsy. However, when a cannabis campaigner becomes proficient at creating the illusion of campaigning for sick children but charges exorbitant prices for cannabis medicine, ethical questions […]
The post The Ethics of Cannabis Campaigning: When Advocacy Turns into Exploitation appeared first on I Am Billy.
Cannabis legalization is a multifaceted issue encompassing various aspects such as prescription cannabis, recreational cannabis, home cultivation, and decriminalization. Each of these areas has unique concerns and advocates, making it crucial for campaigners to stay in their separate lanes. By focusing on their specific objectives, campaigners can more effectively address the needs and priorities of […]
The post Why Cannabis Campaigners Should Stay in Their Separate Lanes appeared first on I Am Billy.
Ryan’s Law or The Compassionate Access to Medical Cannabis Act would allow patients to use medical cannabis in certain situations on hospital grounds. California Governor Gavin Newsom has signed Ryan’s Law legislation into law to expand end-of-life treatment and pain relief options for terminally ill patients.
Late last month, Mastercard decided to halt their debit card transactions with cannabis dispensaries, notifying financial institutions and payment processors to stop processing purchases. This isn’t the first digital payment solution to swiftly exit the industry – late last year, vendors turned off services to their cashless ATMs. These abrupt
Canadian company HEXO has offset 100 percent of its 2020 operational carbon emissions, in addition to the personal emissions of 1,200 employees. HEXO , one of the largest licensed cannabis companies in Canada is a consumer packaged goods company working in the sector under different brands,
Thinking about jetting off this summer? The world’s most pro-cannabis holiday destinations have just been ranked in a new survey. With cannabis becoming increasingly more accessible in many countries across the globe, perhaps it’s not surprising that Google searches for ‘weed friendly vacation spots’ are thought
Like any industry, cannabis can experience ups and downs, especially when it comes to a doors-open retail business. Dispensaries that operate in towns or cities that attract tourists experience this more than anyone, seeing sales spike during the busy months and reach lows during the off-season.
A new survey has revealed that 31 per cent of respondents use CBD to treat pain – but found that 71 per cent of those do not check the dosage with professionals first. The dosage survey conducted by industry watchdog, Leaf Report, reported that 22 per
Scientists working with the John Hopkins University have published a study showing how a terpene called d-limonene found abundantly in cannabis, and in many citrus fruits, affects the experience of users when it is vapourised together with the well-known psychoactive cannabinoid THC. Researchers working on the
Cannabis has been one of the most studied subjects in recent times with much of the focus placed on its medicinal and recreational properties. However, in what has been described as ‘exciting new research’, cannabis is now being investigated for its potential use in pesticides. Working
The German Health Minister Karl Lauterbach has said he is confident that the country’s plans to legalise cannabis for adult use could move ahead, after receiving “very good feedback” from the European Commission. EU approval for Germany’s cannabis bill is one of the few remaining stumbling
A study published in the New England Journal of Medicine has found that patients given ketamine for the treatment of non-psychotic, treatment-resistant depression reported ‘non-inferior’ outcomes compared to electroconvulsive therapy. Electroconvulsive therapy (ECT) is a treatment that involves passing an electric current through a patient’s brain,
Rates of crime in communities where state-licensed cannabis dispensaries have been opened in the US have been found by a recent study not to rise, but in fact, stay neutral. Opponents to the legalisation of cannabis and to the introduction of retail cannabis stores often express
Researchers concerned with the lack of regulation in the rolling paper industry have published a study in which they analysed 53 rolling paper products available on the US consumer market. The objective of the study, published in the journal ACS Omega was to evaluate if these
Cannabis, once stigmatized and criminalized, has emerged as a powerful medicinal substance. With growing research and changing perceptions, the therapeutic potential of cannabis is becoming widely recognized. This blog explores the transformative role of cannabis in modern medicine, highlighting its benefits, applications, and the science behind its efficacy. A Brief History of Cannabis in Medicine […]
The post The Power of Cannabis as Medicine appeared first on I Am Billy.
In a press release sent out today, Emerald Holding, Inc. announced they have completed their acquisition of MJBiz for $120 million. Emerald Holding, Inc. is a large, publicly traded business-to-business events producer and content conglomerate with a number of publications and events in industries like design,
Cannabis brands are facing a proverbial fork in the road: determining whether their product evolves into a luxury consumable or affordable agricultural commodity. While it is reasonable to assume the cannabis market space will organically grow into a luxury goods industry such as wine and spirits,
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do
An Italian court has overturned a decree classifying hemp as a narcotic, siding with cannabis associations which argued for the use of the whole plant. Italy’s Regional Administrative Court of Lazio (TAR) has annulled a decree from January 2022, that limited hemp production to the use
Via Business of Cannabis The French National Medicines Safety Agency (ANSM) has confirmed that flowers will not be included in its upcoming generalised medical cannabis framework. While not wholly unexpected, the abrupt nature and failure of the ANSM to provide any viable alternative to patients currently
In recent years, a number of cannabis-based medicinal products have been investigated for their potential in treating symptoms associated with Multiple Sclerosis (MS). Multiple sclerosis is a chronic condition of the nervous system affecting no two patients the same. Common features include visual disturbances, muscle weakness,
At Curaleaf Clinic (formally Sapphire Clinics), we see patients with a range of conditions – such as chronic pain, post-traumatic stress disorder (PTSD) and anxiety. We also have a growing number of patients suffering from these conditions who are military veterans. With a special nod to
New research has been released for patients with Fibromyalgia which has assessed the effects seen in UK patients after being prescribed medical cannabis. Symptoms commonly experienced in Fibromyalgia include anxiety, debilitating fatigue, chronic pain, sensitivity to light, sound, temperature and touch, as well as cognitive symptoms
Sapphire patient, Helen, and Dr James Rucker of Sapphire Medical Clinics spoke to Louise Eccles in The Sunday Times about the rising number of patients prescribed medical cannabis in the UK. Helen explained that “I had taken other medication for my anxiety previously but it gave
Medical cannabis has been available for prescription in the UK since November 2018, and since then an ever-growing number of patients have been able to access these medicines. Now, the UK has approved three vaporisers for the medical use of cannabis, offering specialists doctors the ability
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
